ArticleThe Journal of clinical investigation2023

Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.

Na Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.